Free Trial

Mohit Bansal Analyst Performance

Biopharma Equity Research Analyst at Wells Fargo & Company

Mohit Bansal is a stock analyst at Wells Fargo & Company in the healthcare sector, covering 24 publicly traded companies. Over the past year, Mohit Bansal has issued 57 stock ratings, including buy and hold recommendations. While full access to Mohit Bansal's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mohit Bansal's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
111 Last 11 Years
Buy Recommendations
63.89% 69 Buy Ratings
Companies Covered
24 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy63.9%69 ratings
Hold36.1%39 ratings
Sell0.0%0 ratings

Out of 108 total stock ratings issued by Mohit Bansal at Wells Fargo & Company, the majority (63.9%) have been Buy recommendations, followed by 36.1% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
79.2% of companies on NASDAQ
19 companies
NYSE
16.7% of companies on NYSE
4 companies
OTCMKTS
4.2% of companies on OTCMKTS
1 company

Mohit Bansal, an analyst at Wells Fargo & Company, currently covers 24 companies listed on NASDAQ, NYSE and OTCMKTS, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
24 companies
100.0%

Mohit Bansal of Wells Fargo & Company specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
16 companies
66.7%
PHARMACEUTICALS
8 companies
33.3%

Mohit Bansal's Ratings History at Wells Fargo & Company

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
11/6/2026Boost Price Target$115.16$110.00Equal Weight
Amgen Inc. stock logo
AMGN
Amgen
11/4/2026Boost Price Target$461.26$460.00Equal Weight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
11/4/2026Lower Price Target$88.97$125.00Overweight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
11/3/2026Boost Price Target$541.01$650.00Overweight
AbbVie Inc. stock logo
ABBV
AbbVie
11/2/2026Boost Price Target$294.80$340.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
11/2/2026Boost Price Target$927.89$925.00Equal Weight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
10/30/2026Boost Price Target$1,372.01$1,500.00Overweight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
10/30/2026Boost Price Target$172.30$190.00Overweight
Biogen Inc. stock logo
BIIB
Biogen
10/20/2026Boost Price Target$239.99$310.00Overweight
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
10/13/2026Lower Price Target$56.49$60.00Equal Weight
Amgen Inc. stock logo
AMGN
Amgen
10/12/2026Lower Price Target$414.87$430.00Equal Weight
Amgen Inc. stock logo
AMGN
Amgen
9/4/2026Boost Price Target$444.12$435.00Equal Weight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
9/4/2026Boost Price Target$150.97$170.00Overweight
AbbVie Inc. stock logo
ABBV
AbbVie
8/17/2026Boost Price Target$249.20$300.00Overweight
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
8/7/2026Boost Price Target$97.91$95.00Equal Weight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
8/6/2026Boost Price Target$1,170.30$1,330.00Overweight
Amgen Inc. stock logo
AMGN
Amgen
8/5/2026Boost Price Target$390.63$400.00Equal Weight
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
8/4/2026Boost Price Target$251.58$300.00Overweight
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
7/31/2026Set Price Target$64.98$65.00Equal Weight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
7/31/2026Boost Price Target$738.90$750.00Equal Weight
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
7/17/2026Boost Price Target$171.93$200.00Overweight
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
7/14/2026Boost Price Target$236.97$285.00Overweight
AbbVie Inc. stock logo
ABBV
AbbVie
7/10/2026Boost Price Target$249.98$295.00Overweight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
7/8/2026Boost Price Target$128.87$150.00Overweight
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
6/12/2026Boost Price Target$50.30$65.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
5/18/2026Lower Price Target$623.32$700.00Equal Weight
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
5/14/2026Lower Price Target$1.60$7.00Overweight
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
5/6/2026Boost Price Target$225.36$265.00Overweight
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
5/6/2026Boost Price Target$43.65$50.00Overweight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
5/6/2026Lower Price Target$93.28$140.00Overweight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
5/1/2026Lower Price Target$113.14$145.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
4/30/2026Lower Price Target$699.16$800.00Equal Weight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
3/12/2026Boost Price Target$116.21$150.00Overweight
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
2/25/2026Boost Price Target$194.17$250.00Overweight
Amgen Inc. stock logo
AMGN
Amgen
2/19/2026Boost Price Target$379.73$375.00Equal Weight
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
2/19/2026Boost Price Target$72.39$75.00Equal Weight
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
2/18/2026Boost Price Target$59.89$75.00Overweight
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
2/13/2026Lower Price Target$126.01$175.00Overweight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2/11/2026Boost Price Target$147.23$165.00Overweight
Biogen Inc. stock logo
BIIB
Biogen
2/8/2026Boost Price Target$201.18$200.00Equal Weight
My public warning after 55 years of watching the markets (Ad)

Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel

See Martin Weiss's full warning before this risk spreads further
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
2/6/2026Reiterated Rating$59.43$60.00Outperform
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
2/5/2026Boost Price Target$1,107.13$1,280.00Overweight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
2/4/2026Boost Price Target$118.49$135.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
2/2/2026Boost Price Target$758.49$800.00Equal Weight
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
1/5/2026Boost Price Target$4.68$5.00Equal Weight
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
12/16/2025Boost Price Target$2.35$8.00Overweight
Amgen Inc. stock logo
AMGN
Amgen
12/10/2025Boost Price Target$313.85$325.00Equal Weight
Biogen Inc. stock logo
BIIB
Biogen
12/10/2025Boost Price Target$175.84$190.00Equal Weight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
12/10/2025Boost Price Target$119.36$150.00Overweight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
12/10/2025Boost Price Target$995.62$1,200.00Overweight
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
12/10/2025Boost Price Target$51.49$55.00Equal Weight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
12/10/2025Boost Price Target$444.95$515.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
12/10/2025Boost Price Target$721.91$745.00Equal Weight
Amgen Inc. stock logo
AMGN
Amgen
11/25/2025Set Price Target$334.30$400.00
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
11/24/2025Upgrade$97.78$125.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
11/20/2025Boost Price Target$748.91$700.00Equal Weight
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
11/18/2025Boost Price Target$180.51$235.00Overweight
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
11/11/2025Boost Price Target$2.53$3.00Equal Weight
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
11/11/2025Boost Price Target$42.89$55.00Overweight
Amgen Inc. stock logo
AMGN
Amgen
11/5/2025Boost Price Target$296.70$300.00Overweight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
10/31/2025Boost Price Target$118.44$145.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
10/29/2025Boost Price Target$655.09$615.00Equal Weight
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
10/28/2025Lower Price Target$54.93$70.00Overweight
AbbVie Inc. stock logo
ABBV
AbbVie
9/12/2025Boost Price Target$220.09$260.00Overweight
Milestone Pharmaceuticals Inc. stock logo
MIST
Milestone Pharmaceuticals
9/11/2025Initiated Coverage$1.71$4.00Overweight
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
9/11/2025Boost Price Target$27.31$35.00Overweight
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
9/11/2025Boost Price Target$38.56$50.00Overweight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
8/6/2025Upgrade$374.98$460.00Overweight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
8/5/2025Set Price Target$110.04$150.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
8/1/2025Downgrade$545.46$580.00Equal Weight
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
7/30/2025Lower Price Target$83.21$90.00Equal Weight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
5/30/2025Downgrade$605.39$580.00Equal Weight
Xenon Pharmaceuticals Inc. stock logo
XENE
Xenon Pharmaceuticals
5/13/2025Lower Price Target$29.95$47.00Overweight
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
5/7/2025Boost Price Target$68.49$65.00Equal Weight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
4/30/2025Lower Price Target$586.51$700.00Overweight
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
4/15/2025Reiterated Rating$0.65$1.00Equal Weight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
3/5/2025Boost Price Target$917.63$1,100.00Overweight
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
3/5/2025Boost Price Target$115.52$140.00Overweight
AbbVie Inc. stock logo
ABBV
AbbVie
3/5/2025Boost Price Target$208.49$240.00Overweight
Jazz Pharmaceuticals PLC stock logo
JAZZ
Jazz Pharmaceuticals
2/13/2025Upgrade$135.44$170.00Overweight
Biogen Inc. stock logo
BIIB
Biogen
2/13/2025Lower Price Target$134.10$140.00Equal Weight
Biogen Inc. stock logo
BIIB
Biogen
2/12/2025Set Price Target$140.64$165.00
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2/12/2025Boost Price Target$104.18$120.00Overweight
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
2/7/2025Boost Price Target$57.21$62.00Equal Weight
AbbVie Inc. stock logo
ABBV
AbbVie
2/3/2025Boost Price Target$188.80$210.00Overweight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
1/30/2025Downgrade$441.52$460.00Equal Weight
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
1/28/2025Lower Price Target$808.16$970.00Overweight
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
1/13/2025Lower Price Target$53.38$57.00Equal Weight
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
1/10/2025Lower Price Target$412.11$460.00Overweight
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
1/10/2025Lower Price Target$733.59$900.00Overweight
Your free book is about to disappear (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
Biogen Inc. stock logo
BIIB
Biogen
1/10/2025Lower Price Target$150.75$165.00Equal Weight
Amgen Inc. stock logo
AMGN
Amgen
1/10/2025Lower Price Target$263.50$280.00Equal Weight
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
12/11/2024Initiated Coverage$116.85$170.00Overweight
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
12/11/2024Initiated Coverage$17.97$30.00Overweight
Vera Therapeutics, Inc. stock logo
VERA
Vera Therapeutics
11/21/2024Initiated Coverage$45.75$70.00Overweight